Evidence for Life Before Inflammatory Bowel Disease

Slides:

Advertisements

Similar presentations

Irritable Bowel Syndrome and Microscopic Colitis: A Systematic Review and Meta- analysis Eline J.C.A. Kamp, John S. Kane, Alexander C. Ford Clinical Gastroenterology.

Advertisements

MiraLAX Is Not as Effective as GoLytely in Bowel Cleansing Before Screening Colonoscopies Michael Hjelkrem, Joel Stengel, Mark Liu, David P. Jones, Stephen.

Risk of Neoplasia After Colectomy in Patients With Inflammatory Bowel Disease: A Systematic Review and Meta-analysis Lauranne A.A.P. Derikx, Loes H.C.

Prevalence and Lifetime Risk of Endoscopy-related Complications Among Patients With Inflammatory Bowel Disease Jason Ferreira, Mona Akbari, Laurie Gashin,

The Role of Psychosocial Care in Adapting to Health Care Reform

Abnormal Liver Tests and Fatty Liver on Ultrasound

Vaccination and Risk for Developing Inflammatory Bowel Disease: A Meta-Analysis of Case–Control and Cohort Studies Guillaume Pineton de Chambrun, Luc.

Millie D. Long, Bruce E. Sands

The Dynamic Nature of Fluid Resuscitation in Acute Pancreatitis

CGH Receives High Impact Factor

Pichamol Jirapinyo, Christopher C. Thompson

Biomarkers of Reflux Disease

Gauree Gupta, Ebbing Lautenbach, James D. Lewis

Celiac Disease and Persistent Symptoms

A Shocking Cystory Clinical Gastroenterology and Hepatology

Todd H. Baron, MD, Thomas C. Smyrk, MD

Portal Hypertensive Enteropathy in Small-Bowel Capsule Endoscopy

Immune Reconstitution Inflammatory Syndrome of the Small Bowel in a Human Immunodeficiency Virus–Negative Patient Severin Daum, Christoph Loddenkemper,

Trends in Overall and Cause-Specific Mortality Among Patients With Inflammatory Bowel Disease From 1982 to 2010 Tine Jess, Morten Frisch, Jacob Simonsen

Inverse Association Between Poor Oral Health and Inflammatory Bowel Diseases Weiyao Yin, Jonas F. Ludvigsson, Zhiwei Liu, Ann Roosaar, Tony Axéll, Weimin.

Laurent Peyrin-Biroulet, Julián Panés, William J

Phillip S. Ge, MD, Bruce A. Runyon, MD

Patient-Reported Outcome Measures for Use in Clinical Trials and Clinical Practice in Inflammatory Bowel Diseases: A Systematic Review Marin J. de Jong,

Stephen A. Harrison, MD, FACP Clinical Gastroenterology and Hepatology

Amnon Sonnenberg, MD, MSc, Brent Y. Lee, MD

Endocuff to Improve Adenoma Detection: Supported by Low-Quality Evidence or Not Supported by High-Quality Evidence? Yao Zhang, MD, Sheng-Bing Zhao, MD

Translating Improved Quality of Care Into an Improved Quality of Life for Patients With Inflammatory Bowel Disease Corey A. Siegel, John I. Allen, Gil.

Interpreting Hepatitis B Surface Antigen Levels: Useful Clinical Test or Just Another Confusing Assay? Brian J. McMahon, MD, Brenna C. Simons, PhD Clinical.

Endoscopic Therapy for Barrett's Esophagus

Traveling Internationally: Avoiding and Treating Travelers' Diarrhea

Amie L. Harvey, Tommy Yen, Anand Kunda

AGA Clinical Practice Update on Functional Gastrointestinal Symptoms in Patients With Inflammatory Bowel Disease: Expert Review Jean-Frederic Colombel,

When Should Screening Stop for Elderly Individuals at Average and Increased Risk for Colorectal Cancer? Folasade P. May, Samir Gupta Clinical Gastroenterology.

Millie D. Long, Hans H. Herfarth, Clare A. Pipkin, Carol Q

Leon P. McLean, Jonathan S. Chun, Raymond K. Cross

Abnormal Liver Tests and Fatty Liver on Ultrasound

Gastroenterology in a New Era of Accountability: Part 2

New Models of Gastroenterology Practice

Reenu Malhotra, Kevin Turner, Amnon Sonnenberg, Robert M. Genta

Laura E. Raffals, Geoffrey C. Nguyen, David T. Rubin

Prevalence and Lifetime Risk of Endoscopy-related Complications Among Patients With Inflammatory Bowel Disease Jason Ferreira, Mona Akbari, Laurie Gashin,

Peter Bytzer Clinical Gastroenterology and Hepatology

Paternal Disease Activity Is Associated With Difficulty in Conception Among Men With Inflammatory Bowel Diseases Ashwin N. Ananthakrishnan, Christopher.

Kavita Patel, Elise Presser, Meaghan George, Mark McClellan

Colorectal Cancer Screening: How to Stop a Moving Target

Effects of Different Coping Strategies on Physical and Mental Health of Patients With Irritable Bowel Syndrome Lilian Dindo, PhD Clinical Gastroenterology.

Risk of Cerebrovascular Accidents and Ischemic Heart Disease in Patients With Inflammatory Bowel Disease: A Systematic Review and Meta-analysis Siddharth.

Knowledge Management: How to Keep up With the Literature

Issue Highlights Clinical Gastroenterology and Hepatology

Risk of Cancer in Patients With Inflammatory Bowel Diseases: A Nationwide Population- based Cohort Study With 30 Years of Follow-up Evaluation Michael.

Alan Bonder, MD, Nezam H. Afdhal, MD

Antje Timmer, Alexandra Bauer, Axel Dignass, Gerhard Rogler

Medical Malpractice in Gastroenterology

Nicolas Williet, William J. Sandborn, Laurent Peyrin–Biroulet

James Allison, Lisa J. Herrinton, Liyan Liu, Jenny Yu, James Lowder

Javier Oliver, Blanca Rueda, Miguel A

A 27-Year-Old Woman With Constipation: Diagnosis and Treatment

Coagulation in Liver Disease: A Guide for the Clinician

Industry Payments to Gastroenterologists Across the United States

Issue Highlights Clinical Gastroenterology and Hepatology

Issue Highlights Clinical Gastroenterology and Hepatology

Coloduodenal Fistula in Crohn’s Disease

Rintaro Hashimoto, Akimichi Chonan

Medical Therapy for Refractory Pediatric Crohn’s Disease

Challenges of NIH Funding for Young Investigators: How the AGA Is Filling the Gap via the AGA Research Foundation Timothy C. Wang, Rhonda F. Souza Clinical.

Issue Highlights Clinical Gastroenterology and Hepatology

Rintaro Hashimoto, Akimichi Chonan

The Role of Psychosocial Care in Adapting to Health Care Reform

Subcapsular Hepatic Fluid Collection Caused by Cardiac Dysfunction

Jordan E. Axelrad, Sharyle A. Fowler, Sonia Friedman, Ashwin N

Presentation transcript:

Evidence for Life Before Inflammatory Bowel Disease Joana Torres, MD, Jean-Frédéric Colombel, MD Clinical Gastroenterology and Hepatology Volume 14, Issue 6, Pages 825-828 (June 2016) DOI: 10.1016/j.cgh.2016.03.006 Copyright © 2016 AGA Institute Terms and Conditions

Figure 1 Proposed phases in the evolution of IBD from health to disease. Intervening (dashed arrow) in the preclinical period of disease could truly represent a window of opportunity to reverse or halt the autoinflammatory process and immune dysregulated pathways from progressing into overt disease. Clinical Gastroenterology and Hepatology 2016 14, 825-828DOI: (10.1016/j.cgh.2016.03.006) Copyright © 2016 AGA Institute Terms and Conditions